CDK19 and AL amyloidosis: To further assess CDK11 for myeloma-selective vulnerability, the study evaluated the expression of CDK11 in human multiple myeloma, and showed that CDK11 is significantly upregulated in expression in primary multiple myeloma tissues, as compared with normal human primary tissues.